Acute rejection of myofibers in nonhuman primates: Key histopathologic features

Journal of Neuropathology and Experimental Neurology

Volumn 71, Issue 5, 2012, Pages 398-412

  Skuk, Daniel ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Acute rejection; Cell transplantation; Histopathology; Myofiber; Skeletal muscle

Indexed keywords

BETA GALACTOSIDASE; TACROLIMUS;

ACUTE GRAFT REJECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INVASION; CELL TRANSPLANTATION; DRUG BLOOD LEVEL; EFFECTOR CELL; ENDOMYSIUM; EPIMYSIUM; FEMALE; GENE EXPRESSION; GRAFT FAILURE; GRAFT SURVIVAL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTIC INFILTRATION; MACACA FASCICULARIS; MACROPHAGE; MALE; MUSCLE BIOPSY; MUSCLE FIBRIL; MYOFIBROBLAST; NONHUMAN; PERIMYSIUM; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD; BETA-GALACTOSIDASE; BIOPSY; CD4-POSITIVE T-LYMPHOCYTES; CELL TRANSPLANTATION; EOSINOPHILS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; MACACA FASCICULARIS; MALE; MODELS, ANIMAL; MUSCLE FIBERS, SKELETAL; MYOBLASTS; STREPTAVIDIN; TACROLIMUS; TIME FACTORS;

EID: 84860218836     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31825243ae     Document Type: Article

References (45)

1. Skuk D. Myoblast transplantation for inherited myopathies: A clinical approach. Expert Opin Biol Ther 2004;4:1871-85 (Pubitemid 39627139)
2. Neil DA, Hubscher SG. Current views on rejection pathology in liver transplantation. Transpl Int 2010;23:971-83
3. Patel JK, Kittleson M, Kobashigawa JA. Cardiac allograft rejection. Surgeon 2011;9:160-67
4. Henderson LK, Nankivell BJ, Chapman JR. Surveillance protocol kidney transplant biopsies: Their evolving role in clinical practice. Am J Transplant 2011;11:1570-75
5. Skuk D, Goulet M, Roy B, et al. Dystrophin expression in muscles of Duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J Neuropathol Exp Neurol 2006;65:371-86 (Pubitemid 44264834)
6. Skuk D, Goulet M, Roy B, et al. First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: Eighteen months follow-up. Neuromuscul Disord 2007;17:38-46 (Pubitemid 46188617)
7. Kinoshita I, Vilquin JT, Guerette B, et al. Immunosuppression with FK 506 insures good success of myoblast transplantation in MDX mice. Transplant Proc 1994;26:3518
8. Kinoshita I, Vilquin JT, Guerette B, et al. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve 1994;17:1407-15 (Pubitemid 24362813)
9. Kinoshita I, Roy R, Dugre FJ, et al. Myoblast transplantation in monkeys: Control of immune response by FK506. J Neuropathol Exp Neurol 1996; 55:687-97 (Pubitemid 26187395)
10. Skuk D, GouletM, Roy B, et al. Myoblast transplantation in whole muscle of nonhuman primates. J Neuropathol Exp Neurol 2000;59:197-206 (Pubitemid 30143878)
11. McDouall RM, Dunn MJ, Dubowitz V. Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy. J Neurol Sci 1990;99:199-217 (Pubitemid 20387378)
12. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. IV: Cell-mediated cytotoxicity and muscle fiber necrosis. Ann Neurol 1988;23:168-73 (Pubitemid 18081455)
13. Pavlath GK, Rando TA, Blau HM. Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers. J Cell Biol 1994;127:1923-32
14. Guerette B, Asselin I, Vilquin JT, et al. Lymphocyte infiltration following allo-and xenomyoblast transplantation in mdx mice. Muscle Nerve 1995; 18:39-51
15. Irintchev A, Zweyer M, Wernig A. Cellular and molecular reactions in mouse muscles after myoblast implantation. J Neurocytol 1995;24:319-31
16. Wernig A, Irintchev A. "Bystander" damage of host muscle caused by implantation of MHC-compatible myogenic cells. J Neurol Sci 1995; 130:190-96
17. Wernig A, Irintchev A, Lange G. Functional effects of myoblast implantation into histoincompatible mice with or without immunosuppression. J Physiol (Lond) 1995;484:493-504
18. Skuk D, Caron NJ, Goulet M, et al. Dynamics of the early immune cellular reactions after myogenic-cell transplantation. Cell Transplant 2002; 11:671-81 (Pubitemid 36026445)
19. Mestas J, Hughes CC. Of mice and not men: Differences between mouse and human immunology. J Immunol 2004;172:2731-38 (Pubitemid 38263654)
20. Rose SM, Blustein N, Rotrosen D. Recommendations of the expert panel on ethical issues in clinical trials of transplant tolerance. National Institute of Allergy and Infectious Diseases of the National Institutes of Health. Transplantation 1998;66:1123-25 (Pubitemid 28530311)
21. Kirk AD. Transplantation tolerance: A look at the nonhuman primate literature in the light of modern tolerance theories. Crit Rev Immunol 1999;19:349-88 (Pubitemid 30053171)
22. Kirk AD. Crossing the bridge: Large animal models in translational transplantation research. Immunol Rev 2003;196:176-96 (Pubitemid 37468111)
23. Slierendregt BL, van Noort JT, Bakas RM, et al. Evolutionary stability of transspecies major histocompatibility complex class II DRB lineages in humans and rhesus monkeys. Hum Immunol 1992;35:29-39 (Pubitemid 23019543)
24. Geluk A, Elferink DG, Slierendregt BL, et al. Evolutionary conservation of major histocompatibility complex-DR/peptide/T cell interactions in primates. J Exp Med 1993;177:979-87 (Pubitemid 23097387)
25. Jaeger EE, Bontrop RE, Lanchbury JS. Structure, diversity, and evolution of the T-cell receptor VB gene repertoire in primates. Immunogenetics 1994;40:184-91 (Pubitemid 24217860)
26. Levinson G, Hughes AL, Letvin NL. Sequence and diversity of rhesus monkey T-cell receptor beta chain genes. Immunogenetics 1992;35:75-88
27. Cendales LC, Xu H, Bacher J, et al. Composite tissue allotransplantation: Development of a preclinical model in nonhuman primates. Transplantation 2005;80:1447-54 (Pubitemid 41803628)
28. Ham RG, St. Clair JA, Webster C, et al. Improved media for normal human muscle satellite cells: Serum-free clonal growth and enhanced growth with low serum. In Vitro Cell Dev Biol 1988;24:833-44
29. Skuk D, Goulet M, Paradis M, et al. Myoblast transplantation: Techniques in nonhuman primates as a bridge to clinical trials. In: Soto-Gutierrez A, Navarro-Alvarez N, Fox IJ, eds. Methods in Bioengineering: Cell Transplantation. Boston, MA: Artech House, 2011;219-36
30. Skuk D, Goulet M, Tremblay JP. Use of repeating dispensers to increase the efficiency of the intramuscular myogenic cell injection procedure. Cell Transplant 2006;15:659-63 (Pubitemid 44904677)
31. Richard PL, Gosselin C, Laliberte T, et al. A first semimanual device for clinical intramuscular repetitive cell injections. Cell Transplant 2010;19: 67-78
32. Kostova E, Rottger S, Schempp W, et al. Identification and characterization of the cynomolgus monkey chromodomain gene cynCDY, an orthologue of the human CDY gene family. Mol Hum Reprod 2002;8: 702-9
33. Kozakowski N, Regele H. Biopsy diagnostics in renal allograft rejection: From histomorphology to biological function. Transpl Int 2009; 22:945-53
34. Tan CD, Baldwin WM 3rd, Rodriguez ER. Update on cardiac transplantation pathology. Arch Pathol Lab Med 2007;131:1169-91 (Pubitemid 47260523)
35. Goldman M, Le Moine A, Braun M, et al. A role for eosinophils in transplant rejection. Trends Immunol 2001;22:247-51 (Pubitemid 32667511)
36. Jones TR, Humphrey PA, Brennan DC. Transplantation of vascularized allogeneic skeletal muscle for scalp reconstruction in a renal transplant patient. Transplantation 1998;65:1605-10 (Pubitemid 28304595)
37. Glotz D, Lucchiari N, Pegaz-Fiornet B, et al. Endothelial cells as targets of allograft rejection. Transplantation 2006;82:S19YS21
38. Dalakas MC. Muscle biopsy findings in inflammatory myopathies. Rheum Dis Clin North Am 2002;28:779-98 (Pubitemid 36008552)
39. Hohlfeld R, Engel AG, Goebels N, et al. Cellular immune mechanisms in inflammatory myopathies. Curr Opin Rheumatol 1997;9:520-26 (Pubitemid 27504209)
40. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984;16:193-208 (Pubitemid 14062666)
41. Engel AG, Arahata K. Mononuclear cells in myopathies: Quantitation of functionally distinct subsets, recognition of antigen-specific cellmediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol 1986;17: 704-21 (Pubitemid 16070409)
42. Benveniste O, Dubourg O, Herson S. New classifications and pathophysiology of the inflammatory myopathies. Rev Med Interne 2007;28: 603-12 (Pubitemid 47299267)
43. Dalakas MC. Pathophysiology of inflammatory and autoimmune myopathies. Presse Med 2011;40:e237-47
44. Dalakas MC. Review: An update on inflammatory and autoimmune myopathies. Neuropathol Appl Neurobiol 2011;37:226-42
45. Skuk D, Goulet M, Roy B, et al. Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: Toward defining strategies applicable to humans. Exp Neurol 2002;175:112-26 (Pubitemid 34507914)